The generation of a conditional Fmr1 knock out mouse model to study Fmrp function in vivo
- PMID: 16257225
- DOI: 10.1016/j.nbd.2005.08.019
The generation of a conditional Fmr1 knock out mouse model to study Fmrp function in vivo
Abstract
The FMR1 gene, mutated in Fragile X syndrome patients, has been modeled in mice with a neomycin cassette inserted in exon 5 of the mouse Fmr1 gene creating an Fmr1 knockout (Fmr1 KO) allele. This results in animals lacking Fmr1 protein (Fmrp) expression in all tissues. We have created a new, more versatile Fmr1 in vivo KO model (Fmr1 KO2) and generated conditional Fmr1 KO (CKO) mice by flanking the promoter and first exon of Fmr1 with lox P sites. This enables us to create a null allele in specific cell types and at specific time points by crossing Fmr1 CKO mice with tissue specific or inducible cre-recombinase expressing mice. The new Fmr1 KO2 line does not express any Fmrp and also lacks detectable Fmr1 transcripts. Crossing the Fmr1 CKO line with a Purkinje cell-specific cre-recombinase expresser produces mice that are null for Fmr1 in Purkinje neurons but wild type in all other cell types.
Similar articles
-
Exaggerated behavioral phenotypes in Fmr1/Fxr2 double knockout mice reveal a functional genetic interaction between Fragile X-related proteins.Hum Mol Genet. 2006 Jun 15;15(12):1984-94. doi: 10.1093/hmg/ddl121. Epub 2006 May 4. Hum Mol Genet. 2006. PMID: 16675531
-
Fmr1 knockout mice are impaired in a leverpress escape/avoidance task.Genes Brain Behav. 2006 Aug;5(6):467-71. doi: 10.1111/j.1601-183X.2005.00183.x. Genes Brain Behav. 2006. PMID: 16923151
-
Altered anxiety-related and social behaviors in the Fmr1 knockout mouse model of fragile X syndrome.Genes Brain Behav. 2005 Oct;4(7):420-30. doi: 10.1111/j.1601-183X.2005.00123.x. Genes Brain Behav. 2005. PMID: 16176388
-
Social behavior phenotypes in fragile X syndrome, autism, and the Fmr1 knockout mouse: theoretical comment on McNaughton et al. (2008).Behav Neurosci. 2008 Apr;122(2):483-9. doi: 10.1037/0735-7044.122.2.483. Behav Neurosci. 2008. PMID: 18410188 Review.
-
The fragile X syndrome: exploring its molecular basis and seeking a treatment.Expert Rev Mol Med. 2006 Apr 21;8(8):1-16. doi: 10.1017/S1462399406010751. Expert Rev Mol Med. 2006. PMID: 16626504 Review.
Cited by
-
Mouse Genetic Models of Human Brain Disorders.Front Genet. 2016 Mar 23;7:40. doi: 10.3389/fgene.2016.00040. eCollection 2016. Front Genet. 2016. PMID: 27047540 Free PMC article. Review.
-
Cerebellar contribution to autism-relevant behaviors in fragile X syndrome models.Cell Rep. 2023 Dec 26;42(12):113533. doi: 10.1016/j.celrep.2023.113533. Epub 2023 Dec 3. Cell Rep. 2023. PMID: 38048226 Free PMC article.
-
A sound-driven cortical phase-locking change in the Fmr1 KO mouse requires Fmr1 deletion in a subpopulation of brainstem neurons.Neurobiol Dis. 2022 Aug;170:105767. doi: 10.1016/j.nbd.2022.105767. Epub 2022 May 17. Neurobiol Dis. 2022. PMID: 35588990 Free PMC article.
-
Acamprosate in a mouse model of fragile X syndrome: modulation of spontaneous cortical activity, ERK1/2 activation, locomotor behavior, and anxiety.J Neurodev Disord. 2017 Jun 12;9:6. doi: 10.1186/s11689-017-9184-y. eCollection 2017. J Neurodev Disord. 2017. PMID: 28616095 Free PMC article.
-
Therapeutic efficacy of the BKCa channel opener chlorzoxazone in a mouse model of Fragile X syndrome.Neuropsychopharmacology. 2024 Dec;49(13):2032-2041. doi: 10.1038/s41386-024-01956-6. Epub 2024 Sep 2. Neuropsychopharmacology. 2024. PMID: 39223257
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Molecular Biology Databases
Research Materials
